Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in Chronic Coronary Syndromes Without Revascularization
NCT05347069Phase 4Recruiting
- Start
- Jun 2022
- Primary completion
- Mar 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in Chronic Coronary Syndrome (CCS). Started Jun 2022; status: recruiting.
02
Drugs
aspirin
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on NCT05347069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05347069.